Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1059 | 1016 | 1174 | 1176 | 1943 | 2663 |
Fund Return | 5.85% | 1.61% | 17.39% | 5.54% | 14.2% | 10.29% |
Place in category | 279 | 237 | 285 | 54 | 39 | 45 |
% in Category | 72 | 61 | 74 | 19 | 17 | 27 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Dreyfus Strategic Value I | 4.12B | 9.12 | 11.35 | 11.13 | ||
Dreyfus International Stock I | 3.54B | 5.97 | 0.98 | 6.67 | ||
Dreyfus Stock Index Fund Initial Cl | 3.19B | 11.16 | 9.27 | 12.40 | ||
Dreyfus International Stock Y | 2.62B | 5.97 | 1.02 | 6.68 | ||
Dreyfus S&P 500 Index | 2.39B | 11.07 | 9.01 | 12.13 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
American Funds New Perspective A | 60.51B | 9.16 | 3.05 | 10.49 | ||
American Funds New Perspective R6 | 35.85B | 9.32 | 3.38 | 10.83 | ||
Old Westbury Large Cap Strategies | 24.15B | 10.94 | 3.63 | 7.49 | ||
American Funds New Perspective F2 | 18.41B | 9.26 | 3.27 | 10.72 | ||
American Funds New Economy A | 16.87B | 10.14 | 2.18 | 10.14 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 8.94 | 446.95 | -1.30% | |
Novo Nordisk ADR | US6701002056 | 5.74 | 142.74 | -1.21% | |
Apple | US0378331005 | 5.16 | 210.61 | -1.63% | |
Amazon.com | US0231351067 | 4.93 | 193.25 | -2.33% | |
Alphabet C | US02079K1079 | 4.52 | 183.42 | -1.84% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review